Iovance Biotherapeutics, Inc.
Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapy
Last updated:
Abstract:
The present invention provides improved and/or shortened methods for expanding TILs and producing therapeutic populations of TILs, including novel methods for expanding TIL populations in a closed system that lead to improved efficacy, improved phenotype, and increased metabolic health of the TILs in a shorter time period, while allowing for reduced microbial contamination as well as decreased costs. Such TILs find use in therapeutic treatment regimens.
Status:
Grant
Type:
Utility
Filling date:
21 Jun 2021
Issue date:
22 Feb 2022